Olema Pharmaceuticals Stock Target Price and Analyst Consensus

OLMA Stock  USD 12.62  0.36  2.77%   
The current analyst and expert consensus on Olema Pharmaceuticals is Strong Buy, with 6 strong buy opinions. The current projected Olema Pharmaceuticals target price consensus is 22.00 with 9 analyst opinions. The most common way Olema Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Olema Pharmaceuticals executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Olema Pharmaceuticals. We strongly encourage you to use your own analysis of Olema Pharmaceuticals to validate this buy or sell advice. Olema Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Olema Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Olema Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.
Lowest Forecast
20.02
Highest Forecast
24.42
Target Price
22
As of September 25, 2024, Gross Profit is expected to decline to about (395.9 K). At present, Olema Pharmaceuticals' Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 22.7 M, whereas Total Assets are forecasted to decline to about 208 M.
  
It's important to approach Olema Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Olema Pharmaceuticals price targets

Olema Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Olema Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Olema Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Olema Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Olema Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Olema Pharmaceuticals is a key component of Olema Pharmaceuticals valuation and have some predictive power on the future returns of a Olema Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Olema Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
8.3812.7317.08
Details
Intrinsic
Valuation
LowRealHigh
10.2014.5518.90
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.63-0.58-0.5
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Olema Pharmaceuticals. Your research has to be compared to or analyzed against Olema Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Olema Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Olema Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Dividend Beast Idea
Dividend Beast
Invested over 60 shares
Blockchain Idea
Blockchain
Invested few shares
Impulse Idea
Impulse
Invested over 100 shares
Business Services Idea
Business Services
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 70 shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 60 shares

Additional Information and Resources on Investing in Olema Stock

When determining whether Olema Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Olema Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Olema Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Olema Pharmaceuticals Stock:
Check out Macroaxis Advice on Olema Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Please note, the presentation of Olema Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Olema Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Olema Pharmaceuticals' management manipulating its earnings.